CClinicalTrials.gg
CompletedNCT07384338Updated Feb 3, 2026

Three Dimensional Evaluation of Dento-Skeletal Effects of Leaf Self Expander in Cleft Lip and Palate Patients

An interventional study of Rapid maxillary expansion and Leaf Self Expander in Three Dimensional, Dento-Skeletal and Leaf Self Expander, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 3 Months to 24 Months. Per ClinicalTrials.gov, last updated 2026-02-03.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Sep 2023, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
3 Months to 24 Months
Sex
All
01

Study summary

This study aims to evaluate the dento-alveolar changes after maxillary expansion in cleft lip and palate patients by Leaf Self Expander, as compared to conventional Rapid Maxillary Expander using digital cast analysis and three-dimensional cone-beam computed tomography.

Read the detailed description

Orofacial clefts are the most prevalent among congenital malformations, which can involve the upper lip, alveolar ridge or/and the palate and, in general, cause esthetic, functional, and psychosocial impairments in different magnitudes, depending on its location and extension.

The Leaf Self Expander (LSE) is a new technology that similar to LE in design except absence of the reactivation screw and respects the principle of producing predetermined light, constant forces, without any intervention by the patient, parents or orthodontist. Where it is composed of three leaf springs compressed by the laboratory before delivery, it is deactivated spontaneously until the programmed expansion is achieved.

02

Conditions studied

  • Three Dimensional
  • Dento-Skeletal
  • Leaf Self Expander
  • Cleft Lip
  • Cleft Palate
03

In context

Cleft Lip

162 studies on the registry are indexed under Cleft Lip; 51 are open to participants now.

This study's enrollment of 20 is below the median of 30 across 114 interventional studies indexed under Cleft Lip.

Browse Cleft Lip studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with unilateral or bilateral cleft lip and palate in mixed dentition.
  • Lip and palate repair was performed from 3 to 24 months of age.
  • Presence of maxillary constriction and need of maxillary expansion prior to secondary alveolar bone grafting.
  • Good periodontal health.

Exclusion criteria

Exclusion Criteria:

  • Previous orthodontic treatments.
  • Any systemic diseases.
  • Multiple carious lesions.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Group A (Control group)

    Patients were treated with conventional therapy with rapid maxillary expansion (RME) for maxillary expansion. Patients were treated with Leaf Self Expander for maxillary expansion.

    Other: Rapid maxillary expansion

  • Experimental
    Group B (Tested group)

    Patients were treated with Leaf Self Expander for maxillary expansion.

    Other: Leaf Self Expander

Interventions

  • OtherRapid maxillary expansion

    Patients were treated with conventional therapy with rapid maxillary expansion (RME) for maxillary expansion.

  • OtherLeaf Self Expander

    Patients were treated with Leaf Self Expander for maxillary expansion.

06

What researchers measure

Primary outcomes

  1. Measurement of linear skeletal change

    Linear skeletal change was assessed to evaluate change in skeletal dimensions following the expansion procedure.

    Time frame: 6 months post-expansion

Secondary outcomes

  1. Measurement of angular skeletal change

    Angular skeletal change was assessed to evaluate change in skeletal dimensions following the expansion procedure.

    Time frame: 6 months post-expansion

  2. Measurement of linear dental change

    Linear dental change was assessed to evaluate change in tooth position and arch dimensions following the expansion procedure.

    Time frame: 6 months post-expansion

  3. Measurement of angular dental change

    Angular dental change was assessed to evaluate change in tooth position and arch dimensions following the expansion procedure.

    Time frame: 6 months post-expansion

07

Study locations

1 site
  • Al-Azhar University
    Cairo, 11651, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07384338
Lead sponsor
Al-Azhar University
Responsible party
Tasneem Ahmed Almohamady Khalil (Assistant lecturer, Orthodontic Department, Faculty of Oral and Dental Medicine, MUST University., Al-Azhar University) — Principal investigator
First posted
Feb 3, 2026
Start date
Sep 1, 2023
Primary completion
Sep 1, 2025
Completion
Sep 1, 2025
Last update
Feb 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion